Abstract
The OncoDB.HCC (http://oncodb.hcc.ibms.sinica.edu.tw) is based on physical maps of rodent and human genomes containing quantitative trait loci of rodent HCC models and various human HCC somatic aberrations including chromosomal data from loss of heterozygosity and comparative genome hybridization analyses, altered expression of genes from microarray and proteomic studies, and finally experimental data of published HCC genes. Comprehensive integration of HCC genomic aberration data avoids potential pitfalls of data inconsistency from single genomic approach and provides lines of evidence to reveal somatic aberrations from levels of DNA, RNA to protein. Twenty-nine of 30 (96.7%) novel HCC genes with significant altered expressions in compared between tumor and adjacent normal tissues were validated by RT-PCR in 45 pairs of HCC tissues and by matching expression profiles in 57 HCC patients of re-analyzed Stanford HCC microarray data. Comparative mapping of HCC loci in between human aberrant chromosomal regions and QTLs of rodent HCC models revealed 12 syntenic HCC regions with 2 loci effectively narrowed down to 2 Mb. Together, OncoDB.HCC graphically presents comprehensive HCC data integration, reveals important HCC genes and loci for positional cloning and functional studies, and discloses potential molecular targets for improving HCC diagnosis and therapy.
MeSH Terms
Animals
Carcinoma, Hepatocellular/genetics,metabolism
Chromosome Aberrations
Databases, Genetic
Gene Expression Profiling
Genes, Neoplasm
Genome, Human
Genomics
Humans
Internet
Liver Neoplasms/genetics,metabolism
Liver Neoplasms, Experimental/genetics
Mice
Physical Chromosome Mapping
Quantitative Trait Loci
Rats
Systems Integration
User-Computer Interface
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Su Wen-Hui
Graduate Institute of Life Sciences, National Defense Medical Center, National Defense University, Taipei 114, Taiwan.
Chao Chuan-Chuan
Yeh Shiou-Hwei
Chen Ding-Shinn
Chen Pei-Jer
Jou Yuh-Shan
References (15)
15 references, click to expand
-
The hallmarks of cancer.
Cell. 2000 Jan 7;100(1):57-70
PMID: 10647931
-
Loss of heterozygosity analysis: practically and conceptually flawed?
Genes Chromosomes Cancer. 2002 Aug;34(4):349-53
PMID: 12112523
-
Molecular pathogenesis of human hepatocellular carcinoma.
Nat Genet. 2002 Aug;31(4):339-46
PMID: 12149612
-
Gene expression profiling of preneoplastic liver disease and liver cancer: a new era for improved early detection and treatment of these deadly diseases?
Carcinogenesis. 2003 Mar;24(3):363-9
PMID: 12663493
-
Chromosomal instability and human hepatocarcinogenesis.
Histol Histopathol. 2003 Jul;18(3):897-909
PMID: 12792902
-
Chromosome aberrations in solid tumors.
Nat Genet. 2003 Aug;34(4):369-76
PMID: 12923544
-
Analysing differential gene expression in cancer.
Nat Rev Cancer. 2003 Nov;3(11):869-76
PMID: 14668817
-
Overexpression and amplification of Aurora-A in hepatocellular carcinoma.
Clin Cancer Res. 2004 Mar 15;10(6):2065-71
PMID: 15041727
-
Clustering of minimal deleted regions reveals distinct genetic pathways of human hepatocellular carcinoma.
Cancer Res. 2004 May 1;64(9):3030-6
PMID: 15126338
-
Integrated global profiling of cancer.
Nat Rev Cancer. 2004 Aug;4(8):638-44
PMID: 15286743
-
Primary liver cancer: worldwide incidence and trends.
Gastroenterology. 2004 Nov;127(5 Suppl 1):S5-S16
PMID: 15508102
-
Global cancer statistics, 2002.
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
PMID: 15761078
-
Progress in concurrent analysis of loss of heterozygosity and comparative genomic hybridization utilizing high density single nucleotide polymorphism arrays.
Cancer Genet Cytogenet. 2005 May;159(1):53-7
PMID: 15860358
-
Integrative analysis of the cancer transcriptome.
Nat Genet. 2005 Jun;37 Suppl:S31-7
PMID: 15920528
-
Clinical cancer proteomics: promises and pitfalls.
J Proteome Res. 2005 Jul-Aug;4(4):1213-22
PMID: 16083271